Updated on: 24 February 2022

Roles in: Z_INACTIVE_Effective Practice and Organisation of Care Group

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the Group/Unit?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
No

b) Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events?
No

c) Fees for organising education?
No

d) Grants and contracts?
Yes - In 2020/2021, I carried out a Cochrane Review that received funding through the Innovative Medicines Initiative (IMI), project number: 806776. The IMI receives funding from Horizon 2020 and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Cochrane's Conflict of Interest Arbiters considered this case and determined that the Innovative Medicines Initiative funding for the review does not breach the Cochrane Commercial Sponsorship Policy. Their decision was based on the fact that there is no direct funding by the pharmaceutical industry. IMI's funding is part of a partnership, with controls and legislation around how the money is spent, and there seems to be extensive canvassing to set the research agenda, which must also align with EU and WHO goals.

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty or licences payments?
No

h) Payment for expert testimony?
No

i) Payment for a fellowship?
No

j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
No

k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the Group/Unit?
No

5. Do you have any other competing interests (financial or non-financial)?
No